Lorenza Wyder - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Lorenza Wyder

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Cancer Immunology, Immunotherapy : CII|May 22, 2025

Targeted CD47 checkpoint blockade using a mesothelin-directed antibody construct for enhanced solid tumor-specific immunotherapyAnna Reischer, Alexandra Leutbecher, Björn Hiller, et al.

Molecular Cancer Therapeutics|July 1, 2010

Potent and selective inhibition of polycythemia by the quinoxaline JAK2 inhibitor NVP-BSK805Fabienne Baffert, Catherine H Régnier, Alain De Pover, et al.

Cancer Discovery|June 12, 2012

Modulation of activation-loop phosphorylation by JAK inhibitors is binding mode dependentRita Andraos, Zhiyan Qian, Débora Bonenfant, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Cancer Immunology, Immunotherapy : CII|May 22, 2025

Targeted CD47 checkpoint blockade using a mesothelin-directed antibody construct for enhanced solid tumor-specific immunotherapyAnna Reischer, Alexandra Leutbecher, Björn Hiller, et al.

Molecular Cancer Therapeutics|July 1, 2010

Potent and selective inhibition of polycythemia by the quinoxaline JAK2 inhibitor NVP-BSK805Fabienne Baffert, Catherine H Régnier, Alain De Pover, et al.

Cancer Discovery|June 12, 2012

Modulation of activation-loop phosphorylation by JAK inhibitors is binding mode dependentRita Andraos, Zhiyan Qian, Débora Bonenfant, et al.

Pageof 2